Naloxone is a centrally acting opioid receptor antagonist. Naloxone binds with the highest affinity to the mu-opioid receptor subtype in the central nervous system (CNS). Naloxone works to reverse opioid overdose and a form of naloxone (Narcan nasal spray) was FDA-approved for over-the-counter (OTC) sale on 29th March 2023.